HEXO (TSX:HEXO) Abruptly Changes Auditors: Should Investors Raise Eyebrows?

Auditors do get changed over time, and it’s encouraged, but investors may raise questions when auditors abruptly resign, as in the HEXO’s case.

| More on:
Person Hands Opening Mailbox To Remove Newspaper

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

HEXO Corp (TSX:HEXO)(NYSE:HEXO) announced on Friday, February 7 that it had changed its auditors effective January 31, 2020, and this could raise some investor concerns, considering the cannabis firm was recently “pressured” to restate its earnings.

The company has changed its auditors from MNP LLP to PricewaterhouseCoopers LLP, and there has been no statutorily required reportable events upon the change, so this could somehow be seen just as an ordinary change of service providers.

But things don’t appear that simple to anyone closely following events at this company.

What we know

At an annual meeting of shareholders on January 20 this year, the company’s shareholders voted to retain MNP LLP as the company’s external audit services provider, only for the re-appointed firm, which had been doing business with the company for more than two years, to abruptly resign just 11 days later.

MNP had been appointed as an external audit services provider mid-year 2018, taking over from Deloitte LLP, which last provided a professional letter in November 2017.

The new service provider received 99.66% of shareholder votes in a January 2019 meeting, but it only garnered 86.6% of the votes in a similar meeting this year (and the trend was largely the same for its six re-elected directors this year, one of which resigned this month).

Shareholders were not as much in agreement in retaining the board and the auditor as they were in January last year, and we could reasonably blame the stock’s dismal price performance in 2019, the revocation of an earlier bullish earnings guidance, declining revenues, and restructuring exercises that added new uncertainty about the future earnings performance for the marijuana operation.

Why the sudden auditor change?

This should be anybody’s guess, but we can reasonably speculate given prior circumstances.

We know that the company recently restated its annual financial results for the fiscal year 2019 ending July 31, and its fiscal first-quarter 2020 results (for the quarter ending October 31, 2019) due to its auditor’s disagreement with management’s application of accounting standards regarding the treatment of deferred taxes at consolidation.

Management had decided to treat deferred taxes at each subsidiary separately, but the audit firm seems to have insisted that they be pooled together in consolidated results. The result was a much better restated earnings report for the year and a lower earnings deficit for this current fiscal year.

As highlighted earlier, another earnings restatement had been done earlier concerning financial assets. The restatement of financial reports can be a significant source of embarrassment to any company, and investors can be tempted to think that the latest change has something to do with the recent clash.

After all, audit firms don’t just resign and give up on lucrative business accounts, especially given the fact that MNP had just been given another year as service provider in a recent shareholder vote last month.

Foolish takeaway

Auditors bring some level of authenticity to a company’s earnings results, and a company should ideally not retain a single firm for far too long, but the change from one such appointed service provider to another should usually be “more orderly” and preferably not through an abrupt resignation days after a reappointment.

The risk to any service corporate provider’s job is that of failing to impress the client. Maybe the outgoing professional team should have been more proactive and advised the changes before the publication of results, but the recent clashes of opinion could have played a role in the professional hire’s sudden departure.

If that was the case, will the new hire always be “more friendly” in the interpretation of international financial reporting standards than the outgoing one?

Happy investing, Fools.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »